gastrointestinal side effects and dose-dependent tolerability issues were the most notable findings, and Phase 3 trials are needed before regulatory submission
Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness
By comparison, those taking Wegovy the highest-dose semaglutide formulation approved for weight loss lost up to 17.4% in a similar time period (68 weeks)
Credentials Breakdown LegitScript Certification Verified LegitScript certification is the industry gold standard for online healthcare providers, and ShedRxs certification shows it meets current standards for safety, compliance, and trustworthy online practices
Slower gastric emptying
Acknowledgements This study was supported by National Key Research and Development Plan Precision Medicine Research (2017YFSF090203), the National Natural Science Foundation of China (81470840, 81873565 and 81800510), Shanghai Sailing Program (18YF1415900), VA Merit Award (I01BX004033 and I01BX001390), and Research Career Scientist Award (IK6BX004477)